Predicting Mortality of COVID-19 in Kidney Transplant Recipients With Developed Scores

Abstract

Objectives: COVID- 19 is a recently discovered ss-subtype coronavirus infection due to SARS-CoV-2. Approximately 20% of COVID- 19 patients have moderate to severe clinical manifestations and 5% progress to critical illness. Kidney transplant patients form a special group. In our study, we aimed to evaluate the success of the COVID-gram score and systemic immuno-inflammation index score in predicting the risk of mortality during hospitalization among kidney transplant patients. Materials and Methods: Our study included 50 kidney transplant patients with positive real- time reverse transcription polymerase chain reaction COVID-19 tests between March 2020 and March 2021. Risk scores were calculated using baseline clinical data collected retrospectively from the patient cohort. Results: The mean age was 54.3 +/- 10.2. The mortality rate was 12%. When we compared the COVID-gram and systemic immuno-inflammation index scores between survivors and nonsurvivors, we did not find any difference. Conclusions: Kidney and other solid-organ transplant patients are at greater risk of infection and mortality than other groups. Accurate risk-predicting tools are imperative for managing the COVID-19 pandemic with limited health resources.